SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007987
Filing Date
2024-05-13
Accepted
2024-05-13 17:01:08
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elut-20240331x10q.htm   iXBRL 10-Q 1510776
2 EX-31.1 elut-20240331xex31d1.htm EX-31.1 15125
3 EX-31.2 elut-20240331xex31d2.htm EX-31.2 15093
4 EX-32.1 elut-20240331xex32d1.htm EX-32.1 6770
5 EX-32.2 elut-20240331xex32d2.htm EX-32.2 6710
  Complete submission text file 0001558370-24-007987.txt   7277480

Data Files

Seq Description Document Type Size
6 EX-101.SCH elut-20240331.xsd EX-101.SCH 58925
7 EX-101.CAL elut-20240331_cal.xml EX-101.CAL 48504
8 EX-101.DEF elut-20240331_def.xml EX-101.DEF 280676
9 EX-101.LAB elut-20240331_lab.xml EX-101.LAB 532794
10 EX-101.PRE elut-20240331_pre.xml EX-101.PRE 412685
80 EXTRACTED XBRL INSTANCE DOCUMENT elut-20240331x10q_htm.xml XML 1061757
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 24940078
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)